{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T04:25:48Z","timestamp":1778732748285,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.neulet.2014.07.014","type":"journal-article","created":{"date-parts":[[2014,7,16]],"date-time":"2014-07-16T23:31:29Z","timestamp":1405553489000},"page":"35-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Neuroprotection by Orexin-A via HIF-1\u03b1 induction in a cellular model of Parkinson's disease"],"prefix":"10.1016","volume":"579","author":[{"given":"Ya","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Te","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Qun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Hong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Cheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2014.07.014_bib0005","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.bbagen.2014.01.004","article-title":"PEP-1\u2013PEA-15 protects against toxin-induced neuronal damage in a mouse model of Parkinson's disease","volume":"1840","author":"Ahn","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neulet.2014.07.014_bib0010","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.febslet.2012.04.032","article-title":"Systemic VHL gene functions and the VHL disease","volume":"586","author":"Bader","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neulet.2014.07.014_bib0015","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s12031-012-9799-0","article-title":"Orexin A suppresses the growth of rat C6 glioma cells via a caspase-dependent mechanism","volume":"48","author":"Bieganska","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neulet.2014.07.014_bib0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11154-013-9259-3","article-title":"Orexin pathways to obesity resistance?","volume":"14","author":"Butterick","year":"2013","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.neulet.2014.07.014_bib0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2012.07.002","article-title":"Orexin A decreases lipid peroxidation and apoptosis in a novel hypothalamic cell model","volume":"524","author":"Butterick","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2014.07.014_bib0030","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.bmc.2013.10.018","article-title":"A perylene derivative regulates HIF-1\u03b1 and Stat3 signaling pathways","volume":"22","author":"Chen","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neulet.2014.07.014_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2009.06443.x","article-title":"Hypoxia-inducible factor 1: a new hope to counteract neurodegeneration?","volume":"112","author":"Correia","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2014.07.014_bib0040","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/jnc.12497","article-title":"Over-expression of an inactive mutant cathepsin D increases endogenous alpha-synuclein and cathepsin B activity in SH-SY5Y cells","volume":"128","author":"Crabtree","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2014.07.014_bib0045","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.neuint.2011.07.005","article-title":"PI3-K\/Akt and ERK pathways activated by VEGF play opposite roles in MPP+-induced neuronal apoptosis","volume":"59","author":"Cui","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neulet.2014.07.014_bib0050","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/brain\/awm090","article-title":"Hypocretin (orexin) loss in Parkinson's disease","volume":"130","author":"Fronczek","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2014.07.014_bib0055","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.neurobiolaging.2011.03.014","article-title":"Hypocretin (orexin) loss in Alzheimer's disease","volume":"33","author":"Fronczek","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2014.07.014_bib0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2008.02.028","article-title":"Reactive oxygen species and HIF-1 signalling in cancer","volume":"266","author":"Galanis","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neulet.2014.07.014_bib0065","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.npep.2013.10.009","article-title":"Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?","volume":"47","author":"Hoyer","year":"2013","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neulet.2014.07.014_bib0070","first-page":"29","article-title":"The regulation of sleep and wakefulness by the hypothalamic neuropeptide orexin\/hypocretin","volume":"75","author":"Inutsuka","year":"2013","journal-title":"Nagoya J. Med. Sci."},{"key":"10.1016\/j.neulet.2014.07.014_bib0075","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neulet.2014.07.014_bib0080","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neulet.2014.07.014_bib0085","doi-asserted-by":"crossref","first-page":"29065","DOI":"10.1074\/jbc.M109.000638","article-title":"Inhibition of prolyl hydroxylase protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson disease","volume":"284","author":"Lee","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2014.07.014_bib0090","first-page":"117","article-title":"Orexin: clinical and therapeutic implications","volume":"58","author":"Mediavilla","year":"2014","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.neulet.2014.07.014_bib0095","doi-asserted-by":"crossref","first-page":"e84767","DOI":"10.1371\/journal.pone.0084767","article-title":"Inhibition of HIF prolyl-4-hydroxylases by FG-4497 reduces brain tissue injury and edema formation during ischemic stroke","volume":"9","author":"Reischl","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.neulet.2014.07.014_bib0100","doi-asserted-by":"crossref","first-page":"e63136","DOI":"10.1371\/journal.pone.0063136","article-title":"Cerebrospinal fluid melanin-concentrating hormone (MCH) and hypocretin-1 (HCRT-1, orexin-A) in Alzheimer's disease","volume":"8","author":"Schmidt","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.neulet.2014.07.014_bib0105","doi-asserted-by":"crossref","first-page":"41732","DOI":"10.1074\/jbc.M504963200","article-title":"Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system","volume":"280","author":"Siddiq","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2014.07.014_bib0110","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1101\/gad.1584307","article-title":"The neurohormone orexin stimulates hypoxia-inducible factor-1 activity","volume":"21","author":"Sikder","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.neulet.2014.07.014_bib0115","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12031-013-0165-7","article-title":"Orexins protect neuronal cell cultures against hypoxic stress: an involvement of Akt signaling","volume":"52","author":"Soko\u0142owska","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neulet.2014.07.014_bib0120","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neulet.2014.07.014_bib0125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/brain\/awh325","article-title":"VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena","volume":"128","author":"Wang","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2014.07.014_bib0130","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1365-2869.2012.01027.x","article-title":"Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?","volume":"21","author":"Wienecke","year":"2012","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.neulet.2014.07.014_bib0135","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuint.2010.05.008","article-title":"Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1\u03b1 and induction of autophagy in SH-SY5Y cells","volume":"57","author":"Wu","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neulet.2014.07.014_bib0140","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/STROKEAHA.112.681700","article-title":"Mitigation of murine focal cerebral ischemia by the hypocretin\/orexin system is associated with reduced inflammation","volume":"44","author":"Xiong","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.neulet.2014.07.014_bib0145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/gt.2009.113","article-title":"AAV9-mediated erythropoietin gene delivery into the brain protects nigral dopaminergic neurons in a rat model of Parkinson's disease","volume":"17","author":"Xue","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.neulet.2014.07.014_bib0150","doi-asserted-by":"crossref","first-page":"e88301","DOI":"10.1371\/journal.pone.0088301","article-title":"A regulatory feedback loop between HIF-1\u03b1 and PIM2 in HepG2 cells","volume":"9","author":"Yu","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.neulet.2014.07.014_bib0155","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/ALN.0b013e318206ff6f","article-title":"Neuroprotective effect of orexin-A is mediated by an increase of hypoxia-inducible factor-1 activity in rat","volume":"114","author":"Yuan","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neulet.2014.07.014_bib0160","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00702-012-0930-8","article-title":"Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson's disease","volume":"120","author":"Zadori","year":"2013","journal-title":"J. Neural Transm."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394014005874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394014005874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T10:53:10Z","timestamp":1538391190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394014005874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":32,"alternative-id":["S0304394014005874"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2014.07.014","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotection by Orexin-A via HIF-1\u03b1 induction in a cellular model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2014.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}